The Vakrangee company is tie up with Max TV for offering subsciptions based OTT plans for public. Offering 350 TV channels, 1000 international channels and 20000 hours of web series.
VAKRANGEE LTD Market Price has broken downtrend line in upside
On April 12, the shares of Vakrangee saw a significant rise in early trading following the announcement of a partnership with Global One Enterprises Pvt Ltd (Max TV). This collaboration aims to provide subscription-based over-the-top (OTT) plans through Vakrangee Kendra networks.
Max TV specializes in offering IPTV/OTT services in India. Their platform boasts a wide array of content, including over 300 Indian FTA channels, 1,000 international channels, and more than 20,000 hours of curated content, encompassing web series, movies, music, live darshans, documentaries, and more.
Through this collaboration, Max TV aims to leverage Vakrangee Kendra networks to market various bundled plans to areas in the country that are currently underserved or unserved.
Vakrangee expressed its commitment to expanding its product and service offerings by partnering with leading businesses. The company aims to become the most reliable physical and online convenience store nationwide, aligning with its new brand philosophy of ‘AB Poori Duniya Pados Mein.’
Metropolis: Metropolis Healthcare reaches 52-week high with debt-free status and robust Q4 update
The Metropolis company announced its debt free company from March 2024, and 15% revenue rise in Year on Year. Sales volumes increased by 8% YoY, Growth of revenue per patient rise by 7%. 18% of revenue is come from B2C segment, growth momentum sustaining manner makes repaying its debt completed.
METROPOLIS HEALTHC Market Price is moving in Ascending channel and market has reached higher high area of the channel
Shares of Metropolis Healthcare Limited saw a significant surge in trading activity, rising by over 6 percent to reach a new 52-week high of Rs 1,916. This increase came as investors celebrated the company’s achievement of becoming debt-free and its impressive 15 percent year-on-year growth in revenue.
During the fourth quarter of the fiscal year 2024, Metropolis recorded an 8 percent year-on-year increase in sales volumes and a 7 percent year-on-year growth in Revenue Per Patient (RPP). The growth was primarily fueled by the speciality tests segment, premium wellness segment, and successful implementation of price increases.
Moreover, the company experienced a notable 18 percent year-on-year growth in Business-to-Consumer (B2C) revenues, indicating sustained demand from individual patients.
The highlight of the quarter was Metropolis Healthcare’s complete repayment of its debt, achieving a debt-free status by March 31, 2024.
In terms of margins, EBITDA margins for Q4FY24 displayed a consistent upward trend both quarter-over-quarter and year-over-year. This margin improvement was mainly attributed to the increase in volumes and implemented price hikes, as stated in a regulatory filing on April 11.
Metropolis Healthcare noted that competition in the industry has shown signs of easing over the last 6 to 12 months, particularly as new players prioritize profitability over aggressive discounting. However, competition remains fierce in certain metropolitan areas, especially within the B2B segment. Despite this, the company has managed to enhance its market share in core geographies and expand its presence in newer territories with an aggressive lab and network expansion strategy.
CAMS: CAMS rises 4% on RBI approval for online payments
The CAMS Company gets approval from RBI for online Payment aggregator and 1.2 million clients registered for Autopay from Mutual funds, Insurance companies.
COMPUTER AGE MNGT SER LTD Market Price is moving in Ascending channel and market has reached higher high area of the channel
Shares of Computer Age Management Services Limited (CAMS) experienced a nearly 4 percent surge in early trading on April 12 following the company’s recent approval to function as an online payment aggregator.
CAMS disclosed to the stock exchange on April 11 that the Reserve Bank of India (RBI) has granted authorization for the company to operate as an online payment aggregator. This approval follows an “in-principle authorization” given by the central bank in February 2023.
In March, CAMSPay, the payments business unit of CAMS, which caters to clients including mutual funds, insurance companies, banks, and NBFCs, registered over 1.2 million mandates for UPI Autopay.
The stock has demonstrated significant growth, rising over 46 percent in the past year and more than 137 percent over the past five years. In the December quarter, CAMS reported an 18 percent increase in EBITDA to Rs 129 crore compared to Rs 109 crore in the previous fiscal year. Revenue also saw a 19 percent year-on-year rise to Rs 290 crore.
Don’t trade all the time, trade forex only at the confirmed trade setups
Get more confirmed trade signals at premium or supreme – Click here to get more signals , 2200%, 800% growth in Real Live USD trading account of our users – click here to see , or If you want to get FREE Trial signals, You can Join FREE Signals Now!
